Table 2.
G-CSF schedule | Without | Pegfilgrastim
|
Filgrastim
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 × 40 μg
|
4 × 10 μg
|
2 × 20 μg
|
|||||||||
Day 0 | Day 1 | Day 2 | Day 0 | Day 1 | Day 2 | Day 0 | Day 1 | Day 2 | |||
Granulocytes | MCC (log ml−1) | 13.0 (0.35) | 13.4 (0.59) | 13.5 (0.30) | 13.5 (0.52) | 13.1 (0.22) | 13.7 (0.44) | 13.1 (0.08) | 12.8 (0.33) | 13.2 (0.21) | 13.2 (0.52) |
AOC (h) | 131.0 (36.7) | 48.0 (28.4) | 46.4 (19.9) | 46.8 (19.7) | 79.5 (26.6) | 39.6 (15.4) | 44.6 (2.7) | 111.6 (36.0) | 108.7 (22.8) | 90.2 (17.1) | |
Monocytes | MCC (log ml−1) | 11.1 (0.42) | 11.6 (0.37) | 11.7 (0.30) | 11.6 (0.20) | 11.5 (0.22) | 11.9 (0.26) | 11.4 (0.11) | 11.1 (0.37) | 11.5 (0.23) | 11.6 (0.30) |
AOC (h) | 158.8 (36.1) | 90.5 (42.1) | 81.1 (19.3) | 83.7 (20.0) | 135.5 (21.5) | 98.4 (15.5) | 99.9 (13.7) | 129.4 (35.6) | 125.0 (31.3) | 142.3 (26.4) | |
Lymphocytes | MCC (log ml−1) | 14.6 (0.43) | 14.5 (0.40) | 14.4 (0.32) | 14.6 (0.19) | 14.0 (0.44) | 14.8 (0.15) | 14.7 (0.21) | 14.3 (0.34) | 14.5 (0.25) | 14.2 (1.1) |
AOC (h) | 172.9 (59.2) | 162.9 (71.3) | 164.8 (20.4) | 146.8 (34.0) | 217.0 (53.3) | 169.6 (28.6) | 182.6 (30.3) | 202.2 (24.8) | 205.2 (25.9) | 203.5 (39.3) |